Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Arthritis, Rheumatoid × Eicosapentaenoic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Weight Loss 2 Psoriasis 1 Osteoarthritis 1 Neoplasms 1 Muscular Atrophy 1 Muscle Weakness 1 Motor Activity 1 Colitis, Ulcerative 1 Cancer Cachexia 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Vitamin D 1 Syringes 1 Lysine Acetyltransferase 5 1 Holistic Health 1 High-Intensity Interval Training 1 Fish Oils 1 Fatty Acids, Omega-3 1 Exercise 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Calcitriol 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01351805 2025-12-03

VITAL

Brigham and Women's Hospital

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡